Alan B. Lancz & Associates, Inc. Sanofi Transaction History
Alan B. Lancz & Associates, Inc.
- $97.3 Million
- Q4 2024
A detailed history of Alan B. Lancz & Associates, Inc. transactions in Sanofi stock. As of the latest transaction made, Alan B. Lancz & Associates, Inc. holds 5,250 shares of SNY stock, worth $285,285. This represents 0.26% of its overall portfolio holdings.
Number of Shares
5,250
Previous 6,050
13.22%
Holding current value
$285,285
Previous $348,000
27.3%
% of portfolio
0.26%
Previous 0.32%
Shares
10 transactions
Others Institutions Holding SNY
# of Institutions
810Shares Held
267MCall Options Held
2MPut Options Held
1.9M-
Dodge & Cox San Francisco, CA76.3MShares$4.15 Billion2.67% of portfolio
-
Morgan Stanley New York, NY17.8MShares$966 Million0.08% of portfolio
-
Ken Fisher Fisher Asset Management, LLC | Camas, Wa13.4MShares$726 Million0.32% of portfolio
-
Invesco Ltd. Atlanta, GA11.7MShares$633 Million0.13% of portfolio
-
Bank Of America Corp Charlotte, NC11.6MShares$629 Million0.06% of portfolio
About Sanofi
- Ticker SNY
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,508,100,096
- Market Cap $136B
- Description
- Sanofi, together with its subsidiaries, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. It operates through three segments: Pharmaceuticals, Vaccines, and Consumer Healthcare. The company provides specialty care products, including human monoclonal antib...